(Q38319523)

2 September 2017

CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth (English)

1 reference

2 September 2017

hepatocellular carcinoma

1 reference

1 reference

Xiaoxing Li

4

0 references

author name string

Kin-Fai Cheung

1

1 reference

2 September 2017

Junhong Zhao

2

1 reference

2 September 2017

Ying Hao

3

1 reference

2 September 2017

Anson W Lowe

5

1 reference

2 September 2017

Alfred S L Cheng

6

1 reference

2 September 2017

Joseph J Y Sung

7

1 reference

2 September 2017

Jun Yu

8

1 reference

2 September 2017

language of work or name

English

0 references

publication date

4 December 2012

1 reference

2 September 2017

1 reference

2 September 2017

119

1 reference

2 September 2017

6

1 reference

2 September 2017

1217-1226

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Developing better treatments in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

The Stanford Microarray Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Cited2, a coactivator of HNF4alpha, is essential for liver development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Identification of novel direct transcriptional targets of glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Maspin (SERPINB5) is an obligate intracellular serpin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

Compartmentalization of TNF-receptor 1 signaling: TNF-R1-associated caspase-8 mediates activation of acid sphingomyelinase in late endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

inferred from DOI database lookup

7 January 2021

based on heuristic

Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27865

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.27865

1 reference

2 September 2017

1 reference